Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This month symbols : NVO save search
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.22%
H: 0.21%
C: -0.34%
vent-02 trial therapeutics results
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.04%
H: 0.19%
C: -1.52%
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.04%
H: 0.19%
C: -1.52%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-08 (Crawled : 13:30) - globenewswire.com
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.62%
H: 0.5%
C: 0.36%
repurchase
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-08 (Crawled : 12:30) - biospace.com/
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.62%
H: 0.5%
C: 0.36%
conference therapeutics
REDUCED secures EUR 6 million financing led by Novo Holdings to scale its natural food ingredients business
Published: 2024-04-04 (Crawled : 06:00) - prnewswire.com
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 1.1%
H: 0.46%
C: -2.32%
business natural million food
2023 Novo Holdings Asia Investments Annual Review/Business Update
Published: 2024-04-03 (Crawled : 07:00) - prnewswire.com
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
investments update asia
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -1.96%
H: 1.3%
C: 1.13%
repurchase
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.